长期抗骨吸收治疗患者的纤维性发育不良显示99mTc-FAPI摄取
本文报道一例40岁女性长病程颅面纤维性发育不良,累及右上颌骨、眶腔及额顶骨,曾行上颌骨部分减容术和眶减压术,目前接受长期抗骨吸收治疗。99mTc-MDP骨显像显示多处成骨活性增高,99mTc-FAPI SPECT/CT显示颅面及其他病灶局灶性摄取,提示成纤维细胞增殖活跃。这是首例报道纤维性发育不良中99mTc-FAPI摄取,提示其可用于评估纤维性骨病灶。
要点
- 纤维性发育不良在长期抗骨吸收治疗下仍可显示99mTc-FAPI局灶性摄取。
- 99mTc-FAPI摄取提示成纤维细胞增殖活跃,有助于评估纤维性骨病灶。
- 这是首例报道纤维性发育不良中99mTc-FAPI摄取的病例。
核心结论
- 99mTc-FAPI SPECT/CT在纤维性发育不良病灶中显示局灶性摄取,提示成纤维细胞增殖活跃,为首例报道。
研究设计与样本
- 个案报道:一例40岁女性长病程颅面纤维性发育不良,累及右上颌骨、眶腔及额顶骨。
主要发现
- 99mTc-MDP骨显像显示多处成骨活性增高灶。
- 99mTc-FAPI SPECT/CT显示颅面及其他病灶局灶性摄取,提示成纤维细胞增殖活跃。
临床怎么用
- 99mTc-FAPI SPECT/CT可能用于评估纤维性骨病灶的成纤维细胞增殖活性。
局限性
- 仅为一例个案报道,结论需更多病例验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We report a rare case of a 40-year-old woman with longstanding craniofacial fibrous dysplasia involving the right maxilla, orbital cavity, and fronto-parietal bones. The patient underwent partial maxillary debulking 7 years ago for cosmetic reasons and orbital decompression 3 years ago, and is currently on long-term antiresorptive therapy. Bone scintigraphy with 99mTc-MDP showed multiple sites of increased osteoblastic activity. 99mTc-FAPI SPECT/CT also revealed focal uptake in craniofacial and other lesions, indicating active fibroblast proliferation. This is the first reported case of 99mTc-FAPI uptake in fibrous dysplasia, suggesting its value in evaluating fibrotic bone lesions.
引用
- Samadi MH, Sahafi P, Emadi Toghabeh A, et al. Fibrous Dysplasia With 99m Tc-FAPI Uptake in a Patient Under Long-term Antiresorptive Therapy. Clin Nucl Med. 2026. PMID: 42410757. doi:10.1097/RLU.0000000000006109
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。